Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications

Brian Dalby1, Sharon Cates, Adam Harris

  • 1Invitrogen Corporation Research and Development, 1610 Faraday Avenue, Carlsbad, CA 92008, USA. brian.dalby@invitrogen.com

Related Concept Videos